AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 145 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $4,774 | +15.7% | 531 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $4,126 | -19.7% | 531 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $5,140 | -11.7% | 531 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $5,820 | +153.7% | 531 | 0.0% | 0.00% | +200.0% |
| Q4 2022 | $2,294 | -42.6% | 531 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $4,000 | -20.0% | 531 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $5,000 | -28.6% | 531 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $7,000 | -41.7% | 531 | 0.0% | 0.00% | -40.0% |
| Q4 2021 | $12,000 | 0.0% | 531 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $12,000 | +71.4% | 531 | 0.0% | 0.01% | +100.0% |
| Q2 2021 | $7,000 | 0.0% | 531 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $7,000 | 0.0% | 531 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $7,000 | – | 531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |